How Clavulanic Acid Inhibits Serine β‐Lactamases
ChemBioChem · 2024
DOI: 10.1002/cbic.202400280 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2024. Verfasst von Pauline A Lang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, United Kingdom. Hauptthemen laut MEDLINE: Clavulanic Acid, beta-Lactamase Inhibitors, beta-Lactamases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National PhD Training Programme in Antimicrobial Resistance Research by the Medical Research Foundation, Wellcome Trust, Medical Research Council.
Abstract (Originalsprache)
Clavulanic acid is a medicinally important inhibitor of serine β‐lactamases (SBLs). We report studies on the mechanisms by which clavulanic acid inhibits representative Ambler class A (TEM‐116), C ( Escherichia coli AmpC), and D (OXA‐10) SBLs using denaturing and non‐denaturing mass spectrometry (MS). Similarly to observations with penam sulfones, most of the results support a mechanism involving acyl enzyme complex formation, followed by oxazolidine ring opening without efficient subsequent scaffold fragmentation (at pH 7.5). This observation contrasts with previous MS studies, which identified clavulanic acid scaffold fragmented species as the predominant SBL bound products. In all the SBLs studied here, fragmentation was promoted by acidic conditions, which are commonly used in LC–MS analyses. Slow fragmentation was, however, observed under neutral conditions with TEM‐116 on prolonged reaction with clavulanic acid. Although our results imply clavulanic acid scaffold fragmentation is likely not crucial for SBL inhibition in vivo, development of inhibitors that fragment to give stable covalent complexes is of interest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry Research Laboratory, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, United Kingdom.
- Ineos Oxford Institute for Antimicrobial Research, Department of Chemistry, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, United Kingdom.
- Physical and Theoretical Chemistry Laboratory, Department of Chemistry, University of Oxford, South Parks Road, Oxford, OX1 3QZ, United Kingdom.
- Kavli Institute for Nanoscience Discovery, University of Oxford, Sherrington Road, Oxford, OX1 3QU, United Kingdom.
- Enzymology and Applied Biocatalysis Research Center, Faculty of Chemistry and Chemical Engineering, Babes-Bolyai University, Str. Arany Janos 11, 400028, Cluj-Napoca, Romania.
ORCID-Profile: Christopher J Schofield
Förderung
- National PhD Training Programme in Antimicrobial Resistance Research by the Medical Research Foundation
- Wellcome Trust
- Medical Research Council
- Biotechnology and Biological Research Council
- Innovative Medicines Initiative
Zitieren
APA
Lang, P. A., de Munnik, M., Oluwole, A. O., Claridge, T. D. W., Robinson, C. V., Brem, J., & Schofield, C. J. (2024). How Clavulanic Acid Inhibits Serine β‐Lactamases. ChemBioChem. https://doi.org/10.1002/cbic.202400280
Vancouver
Lang PA, de Munnik M, Oluwole AO, Claridge TDW, Robinson CV, Brem J, et al. How Clavulanic Acid Inhibits Serine β‐Lactamases. ChemBioChem. 2024. doi:10.1002/cbic.202400280
BibTeX
@article{Lang2024,
author = {Lang, Pauline A and de Munnik, Mariska and Oluwole, Abraham O and Claridge, Timothy D W and Robinson, Carol V and Brem, Jürgen and Schofield, Christopher J},
title = {How Clavulanic Acid Inhibits Serine β‐Lactamases},
journal = {ChemBioChem},
year = {2024},
doi = {10.1002/cbic.202400280}
}
EUVIMED